{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:15:53Z","timestamp":1794334553856,"version":"4.9.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94303-8","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:08:51Z","timestamp":1742368131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multi-omic biomarkers associated with multiple sclerosis: from Mendelian randomization to drug prediction"],"prefix":"10.1038","volume":"15","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"chenglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"3","key":"94303_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"MT Wallin","year":"2019","unstructured":"Wallin, M. T. et al. Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 18(3), 269\u2013285 (2019).","journal-title":"The Lancet Neurology"},{"issue":"11","key":"94303_CR2","doi-asserted-by":"publisher","first-page":"e209351","DOI":"10.1212\/wnl.0000000000209351","volume":"102","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Prevalence and burden of multiple sclerosis in China, 1990\u20132019: findings from the global burden of disease study 2019. Neurology 102 (11), e209351. https:\/\/doi.org\/10.1212\/wnl.0000000000209351 (2024).","journal-title":"Neurology"},{"issue":"11","key":"94303_CR3","doi-asserted-by":"publisher","first-page":"103450","DOI":"10.1016\/j.autrev.2023.103450","volume":"22","author":"F Cao","year":"2023","unstructured":"Cao, F. et al. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019. Autoimmun. Rev. 22 (11), 103450. https:\/\/doi.org\/10.1016\/j.autrev.2023.103450 (2023).","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"94303_CR4","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1186\/s12889-024-19290-3","volume":"24","author":"M Zhao","year":"2024","unstructured":"Zhao, M. et al. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in adolescents and young adults (15\u201339 years): an analysis based on the global burden of disease study 2021. BMC Public. Health. 24 (1), 1800. https:\/\/doi.org\/10.1186\/s12889-024-19290-3 (2024).","journal-title":"BMC Public. Health"},{"issue":"10","key":"94303_CR5","doi-asserted-by":"publisher","first-page":"103407","DOI":"10.1016\/j.autrev.2023.103407","volume":"22","author":"DP Li","year":"2023","unstructured":"Li, D. P. et al. A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040. Autoimmun. Rev. 22 (10), 103407. https:\/\/doi.org\/10.1016\/j.autrev.2023.103407 (2023).","journal-title":"Autoimmun. Rev."},{"key":"94303_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60091409","author":"A Gogulescu","year":"2024","unstructured":"Gogulescu, A. et al. Neurological side effects of TNF-\u03b1 inhibitors revisited: A review of case reports. Med. (Kaunas). 60 (9). https:\/\/doi.org\/10.3390\/medicina60091409 (2024).","journal-title":"Med. (Kaunas)"},{"issue":"4","key":"94303_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s40744-024-00674-1","volume":"11","author":"MW So","year":"2024","unstructured":"So, M. W., Kim, A. R. & Lee, S. G. Drug persistence and incidence of active tuberculosis of tumor necrosis factor alpha inhibitors versus Tocilizumab as the First-Line biological treatment in patients with rheumatoid arthritis: A nationwide Population-Based retrospective cohort analysis. Rheumatol. Ther. 11 (4), 881\u2013895. https:\/\/doi.org\/10.1007\/s40744-024-00674-1 (2024).","journal-title":"Rheumatol. Ther."},{"issue":"414","key":"94303_CR8","first-page":"187","volume":"10","author":"PA Varisco","year":"2014","unstructured":"Varisco, P. A. & So, A. [A new therapeutical option for chronic inflammation in rheumatology: Janus kinases inhibitors (JAK)]. Rev. Med. Suisse. 10 (414), 187\u2013191 (2014).","journal-title":"Rev. Med. Suisse"},{"key":"94303_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae444","author":"I Hennessee","year":"2024","unstructured":"Hennessee, I., Benedict, K., Bahr, N. C., Lipner, S. R. & Gold, J. A. W. Incidence and risk factors for invasive fungal infections in patients initiating TNF-alpha inhibitors for inflammatory bowel disease and rheumatoid arthritis. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciae444 (2024).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"94303_CR10","doi-asserted-by":"publisher","first-page":"Cd011381","DOI":"10.1002\/14651858.CD011381.pub3","volume":"1","author":"M Gonzalez-Lorenzo","year":"2024","unstructured":"Gonzalez-Lorenzo, M. et al. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis. Cochrane Database Syst. Rev. 1 (1), Cd011381. https:\/\/doi.org\/10.1002\/14651858.CD011381.pub3 (2024).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"94303_CR11","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53 (12), 1712\u20131721. https:\/\/doi.org\/10.1038\/s41588-021-00978-w (2021).","journal-title":"Nat. Genet."},{"issue":"7982","key":"94303_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK biobank. Nature 622 (7982), 329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6 (2023).","journal-title":"Nature"},{"key":"94303_CR13","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj 362, k601. https:\/\/doi.org\/10.1136\/bmj.k601 (2018).","journal-title":"Bmj"},{"issue":"11","key":"94303_CR14","doi-asserted-by":"publisher","first-page":"e1009922","DOI":"10.1371\/journal.pgen.1009922","volume":"17","author":"Z Lin","year":"2021","unstructured":"Lin, Z., Deng, Y. & Pan, W. Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model. PLoS Genet. 17 (11), e1009922. https:\/\/doi.org\/10.1371\/journal.pgen.1009922 (2021).","journal-title":"PLoS Genet."},{"issue":"3","key":"94303_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess, S. & Thompson, S. G. Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 40 (3), 755\u2013764. https:\/\/doi.org\/10.1093\/ije\/dyr036 (2011).","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"94303_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s12859-021-04531-8","volume":"22","author":"SH Lin","year":"2021","unstructured":"Lin, S. H., Thakur, R. & Machiela, M. J. LDexpress: an online tool for integrating population-specific linkage disequilibrium patterns with tissue-specific expression data. BMC Bioinform. 22 (1), 608. https:\/\/doi.org\/10.1186\/s12859-021-04531-8 (2021).","journal-title":"BMC Bioinform."},{"key":"94303_CR17","doi-asserted-by":"publisher","first-page":"1453147","DOI":"10.3389\/fnut.2024.1453147","volume":"11","author":"X Li","year":"2024","unstructured":"Li, X., Xie, Z., Qiu, H., Xie, X. & Liu, L. Exploring the causal associations between diet-derived Circulating antioxidants and the risk of endometriosis: a Mendelian randomization study. Front. Nutr. 11, 1453147. https:\/\/doi.org\/10.3389\/fnut.2024.1453147 (2024).","journal-title":"Front. Nutr."},{"issue":"7","key":"94303_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37 (7), 658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758 (2013).","journal-title":"Genet. Epidemiol."},{"issue":"1","key":"94303_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/js9.0000000000001926","volume":"111","author":"L Zhou","year":"2024","unstructured":"Zhou, L. et al. Metabolic syndrome and cancer risk: A two-sample Mendelian randomization study of European ancestry. Int. J. Surg. 111 (1), 311\u2013321. https:\/\/doi.org\/10.1097\/js9.0000000000001926 (2024).","journal-title":"Int. J. Surg."},{"issue":"11","key":"94303_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47 (11), 1236\u20131241. https:\/\/doi.org\/10.1038\/ng.3406 (2015).","journal-title":"Nat. Genet."},{"issue":"1","key":"94303_CR21","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41467-022-32219-x","volume":"13","author":"CM Francis","year":"2022","unstructured":"Francis, C. M. et al. Genome-wide associations of aortic distensibility suggest causality for aortic aneurysms and brain white matter hyperintensities. Nat. Commun. 13 (1), 4505. https:\/\/doi.org\/10.1038\/s41467-022-32219-x (2022).","journal-title":"Nat. Commun."},{"issue":"6220","key":"94303_CR22","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347 (6220), 1260419. https:\/\/doi.org\/10.1126\/science.1260419 (2015).","journal-title":"Science"},{"issue":"D1","key":"94303_CR23","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51 (D1), D638\u2013d46. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"key":"94303_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","volume":"127","author":"Y Tang","year":"2015","unstructured":"Tang, Y., Li, M., Wang, J., Pan, Y. & Wu, F. X. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems 127, 67\u201372. https:\/\/doi.org\/10.1016\/j.biosystems.2014.11.005 (2015).","journal-title":"Biosystems"},{"issue":"D1","key":"94303_CR25","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","volume":"45","author":"Expansion of the Gene Ontology knowledgebase and resources","year":"2017","unstructured":"Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res. ;45(D1):D331\u2013d8. https:\/\/doi.org\/10.1093\/nar\/gkw1108 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"94303_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"94303_CR27","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013d7. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"94303_CR28","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"issue":"18","key":"94303_CR29","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo, M. et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics 31 (18), 3069\u20133071. https:\/\/doi.org\/10.1093\/bioinformatics\/btv313 (2015).","journal-title":"Bioinformatics"},{"issue":"D1","key":"94303_CR30","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51 (D1), D1373\u2013d80. https:\/\/doi.org\/10.1093\/nar\/gkac956 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"94303_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/gene.2008.22","volume":"9","author":"IA Hoppenbrouwers","year":"2008","unstructured":"Hoppenbrouwers, I. A. et al. EVI5 is a risk gene for multiple sclerosis. Genes Immun. 9 (4), 334\u2013337. https:\/\/doi.org\/10.1038\/gene.2008.22 (2008).","journal-title":"Genes Immun."},{"issue":"12","key":"94303_CR32","doi-asserted-by":"publisher","first-page":"e26493","DOI":"10.1371\/journal.pone.0026493","volume":"6","author":"N Jafari","year":"2011","unstructured":"Jafari, N., Broer, L., van Duijn, C. M., Janssens, A. C. & Hintzen, R. Q. Perspectives on the use of multiple sclerosis risk genes for prediction. PLoS One. 6 (12), e26493. https:\/\/doi.org\/10.1371\/journal.pone.0026493 (2011).","journal-title":"PLoS One"},{"issue":"1","key":"94303_CR33","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1038\/s41467-024-48165-9","volume":"15","author":"S Soltani","year":"2024","unstructured":"Soltani, S., Webb, S. M., Kroll, T. & King-Jones, K. Drosophila Evi5 is a critical regulator of intracellular iron transport via transferrin and ferritin interactions. Nat. Commun. 15 (1), 4045. https:\/\/doi.org\/10.1038\/s41467-024-48165-9 (2024).","journal-title":"Nat. Commun."},{"issue":"1","key":"94303_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-020-01585-z","volume":"39","author":"T Cai","year":"2020","unstructured":"Cai, T. et al. EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells. J. Exp. Clin. Cancer Res. 39 (1), 84. https:\/\/doi.org\/10.1186\/s13046-020-01585-z (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"94303_CR35","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1038\/s41598-020-64432-3","volume":"10","author":"M Dashti","year":"2020","unstructured":"Dashti, M., Ateyah, K., Alroughani, R. & Al-Temaimi, R. Replication analysis of variants associated with multiple sclerosis risk. Sci. Rep. 10 (1), 7327. https:\/\/doi.org\/10.1038\/s41598-020-64432-3 (2020).","journal-title":"Sci. Rep."},{"key":"94303_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2024.12.029","volume":"567","author":"S Rida Zainab","year":"2025","unstructured":"Rida Zainab, S., Zeb Khan, J., Khalid Tipu, M., Jahan, F. & Irshad, N. A review on multiple sclerosis: unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations. Neuroscience 567, 133\u2013149. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.029 (2025).","journal-title":"Neuroscience"},{"issue":"3","key":"94303_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/hab-170328","volume":"26","author":"M Mazdeh","year":"2017","unstructured":"Mazdeh, M. et al. Ecotropic viral integration site 5 (EVI5) expression analysis in multiple sclerosis patients. Hum. Antibodies. 26 (3), 113\u2013119. https:\/\/doi.org\/10.3233\/hab-170328 (2017).","journal-title":"Hum. Antibodies"},{"key":"94303_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071733","author":"M D'Anca","year":"2021","unstructured":"D\u2019Anca, M. et al. Extracellular vesicles in multiple sclerosis: role in the pathogenesis and potential usefulness as biomarkers and therapeutic tools. Cells 10 (7). https:\/\/doi.org\/10.3390\/cells10071733 (2021).","journal-title":"Cells"},{"issue":"3","key":"94303_CR39","doi-asserted-by":"publisher","first-page":"103874","DOI":"10.1016\/j.isci.2022.103874","volume":"25","author":"F Liu","year":"2022","unstructured":"Liu, F. et al. Sanguinarine promotes healthspan and innate immunity through a conserved mechanism of ROS-mediated PMK-1\/SKN-1 activation. iScience 25 (3), 103874. https:\/\/doi.org\/10.1016\/j.isci.2022.103874 (2022).","journal-title":"iScience"},{"key":"94303_CR40","doi-asserted-by":"publisher","first-page":"116406","DOI":"10.1016\/j.biopha.2024.116406","volume":"173","author":"LJ Huang","year":"2024","unstructured":"Huang, L. J. et al. Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years. Biomed. Pharmacother. 173, 116406. https:\/\/doi.org\/10.1016\/j.biopha.2024.116406 (2024).","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"94303_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1182\/blood-2015-10-679191","volume":"128","author":"E Kotsiou","year":"2016","unstructured":"Kotsiou, E. et al. TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses. Blood 128 (1), 72\u201381. https:\/\/doi.org\/10.1182\/blood-2015-10-679191 (2016).","journal-title":"Blood"},{"issue":"1","key":"94303_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1600-065X.2011.01064.x","volume":"244","author":"MW Steinberg","year":"2011","unstructured":"Steinberg, M. W., Cheung, T. C. & Ware, C. F. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol. Rev. 244 (1), 169\u2013187. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01064.x (2011).","journal-title":"Immunol. Rev."},{"issue":"2","key":"94303_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/gene.2010.42","volume":"12","author":"F Blanco-Kelly","year":"2011","unstructured":"Blanco-Kelly, F. et al. Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition. Genes Immun. 12 (2), 145\u2013148. https:\/\/doi.org\/10.1038\/gene.2010.42 (2011).","journal-title":"Genes Immun."},{"issue":"4","key":"94303_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri2526","volume":"9","author":"M Croft","year":"2009","unstructured":"Croft, M. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9 (4), 271\u2013285. https:\/\/doi.org\/10.1038\/nri2526 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"94303_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2172-14-32","volume":"14","author":"M Jern\u00e5s","year":"2013","unstructured":"Jern\u00e5s, M. et al. MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol. 14, 32. https:\/\/doi.org\/10.1186\/1471-2172-14-32 (2013).","journal-title":"BMC Immunol."},{"issue":"5","key":"94303_CR46","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.immuni.2016.04.019","volume":"44","author":"LK Ward-Kavanagh","year":"2016","unstructured":"Ward-Kavanagh, L. K., Lin, W. W., \u0160ed\u00fd, J. R. & Ware, C. F. The TNF receptor superfamily in Co-stimulating and Co-inhibitory responses. Immunity 44 (5), 1005\u20131019. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.019 (2016).","journal-title":"Immunity"},{"issue":"1","key":"94303_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-024-03193-6","volume":"21","author":"V Mazziotti","year":"2024","unstructured":"Mazziotti, V. et al. The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? J. Neuroinflammation. 21 (1), 209. https:\/\/doi.org\/10.1186\/s12974-024-03193-6 (2024).","journal-title":"J. Neuroinflammation"},{"key":"94303_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063248","author":"P Conti","year":"2024","unstructured":"Conti, P. et al. Impact of TNF and IL-33 cytokines on mast cells in neuroinflammation. Int. J. Mol. Sci. 25 (6). https:\/\/doi.org\/10.3390\/ijms25063248 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"94303_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/1940-6207.Capr-20-0360","volume":"14","author":"TH Nasti","year":"2021","unstructured":"Nasti, T. H. et al. Regulatory T cells play an important role in the prevention of murine melanocytic nevi and melanomas. Cancer Prev. Res. (Phila). 14 (2), 165\u2013174. https:\/\/doi.org\/10.1158\/1940-6207.Capr-20-0360 (2021).","journal-title":"Cancer Prev. Res. (Phila)"},{"issue":"1","key":"94303_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/toxsci\/kfi176","volume":"86","author":"J Gao","year":"2005","unstructured":"Gao, J., Lauer, F. T., Dunaway, S. & Burchiel, S. W. Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity. Toxicol. Sci. 86 (1), 68\u201374. https:\/\/doi.org\/10.1093\/toxsci\/kfi176 (2005).","journal-title":"Toxicol. Sci."},{"issue":"1","key":"94303_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0041-008x(91)90287-o","volume":"110","author":"GS Ladics","year":"1991","unstructured":"Ladics, G. S., Kawabata, T. T. & White, K. L. Jr Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and Inhibition of immunosuppression by alpha-naphthoflavone. Toxicol. Appl. Pharmacol. 110 (1), 31\u201344. https:\/\/doi.org\/10.1016\/0041-008x(91)90287-o (1991).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"94303_CR52","doi-asserted-by":"publisher","first-page":"1209970","DOI":"10.3389\/fimmu.2023.1209970","volume":"14","author":"H Cai","year":"2023","unstructured":"Cai, H. et al. Protein O-GlcNAcylation in multiple immune cells and its therapeutic potential. Front. Immunol. 14, 1209970. https:\/\/doi.org\/10.3389\/fimmu.2023.1209970 (2023).","journal-title":"Front. Immunol."},{"issue":"7","key":"94303_CR53","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.stemcr.2024.05.009","volume":"19","author":"Q Liu","year":"2024","unstructured":"Liu, Q. et al. O-GlcNAcase regulates pluripotency States of human embryonic stem cells. Stem Cell. Rep. 19 (7), 993\u20131009. https:\/\/doi.org\/10.1016\/j.stemcr.2024.05.009 (2024).","journal-title":"Stem Cell. Rep."},{"issue":"2","key":"94303_CR54","doi-asserted-by":"publisher","first-page":"105615","DOI":"10.1016\/j.jbc.2023.105615","volume":"300","author":"ZM Nelson","year":"2024","unstructured":"Nelson, Z. M., Leonard, G. D. & Fehl, C. Tools for investigating O-GlcNAc in signaling and other fundamental biological pathways. J. Biol. Chem. 300 (2), 105615. https:\/\/doi.org\/10.1016\/j.jbc.2023.105615 (2024).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"94303_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13041-022-00906-x","volume":"15","author":"VN Huynh","year":"2022","unstructured":"Huynh, V. N. et al. Acute Inhibition of OGA sex-dependently alters the networks associated with bioenergetics, autophagy, and neurodegeneration. Mol. Brain. 15 (1), 22. https:\/\/doi.org\/10.1186\/s13041-022-00906-x (2022).","journal-title":"Mol. Brain"},{"issue":"11","key":"94303_CR56","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/s12276-021-00709-5","volume":"53","author":"BE Lee","year":"2021","unstructured":"Lee, B. E., Suh, P. G. & Kim, J. I. O-GlcNAcylation in health and neurodegenerative diseases. Exp. Mol. Med. 53 (11), 1674\u20131682. https:\/\/doi.org\/10.1038\/s12276-021-00709-5 (2021).","journal-title":"Exp. Mol. Med."},{"issue":"14","key":"94303_CR57","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1021\/jm010811t","volume":"44","author":"A Carotenuto","year":"2001","unstructured":"Carotenuto, A., D\u2019Ursi, A. M., Nardi, E., Papini, A. M. & Rovero, P. Conformational analysis of a glycosylated human Myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis. J. Med. Chem. 44 (14), 2378\u20132381. https:\/\/doi.org\/10.1021\/jm010811t (2001).","journal-title":"J. Med. Chem."},{"key":"94303_CR58","doi-asserted-by":"publisher","first-page":"100195","DOI":"10.1016\/j.ejmcr.2024.100195","volume":"12","author":"A Sharma","year":"2024","unstructured":"Sharma, A., Singh, A., Debnath, R., Gupta, G. D. & Sharma, K. Role of O-GlcNAcylation in Alzheimer\u2019s disease: insights and perspectives. Eur. J. Med. Chem. Rep. 12, 100195. https:\/\/doi.org\/10.1016\/j.ejmcr.2024.100195 (2024).","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"94303_CR59","doi-asserted-by":"publisher","first-page":"871535","DOI":"10.3389\/fnhum.2022.871535","volume":"16","author":"SM Ostojic","year":"2022","unstructured":"Ostojic, S. M. Guanidinoacetic acid as a nutritional adjuvant to multiple sclerosis therapy. Front. Hum. Neurosci. 16, 871535. https:\/\/doi.org\/10.3389\/fnhum.2022.871535 (2022).","journal-title":"Front. Hum. Neurosci."},{"issue":"12","key":"94303_CR60","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1021\/ml500450c","volume":"5","author":"AF Abdel-Magid","year":"2014","unstructured":"Abdel-Magid, A. F. Inhibition of O-GlcNAcase (OGA): A potential therapeutic target to treat Alzheimer\u2019s disease. ACS Med. Chem. Lett. 5 (12), 1270\u20131271. https:\/\/doi.org\/10.1021\/ml500450c (2014).","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"94303_CR61","doi-asserted-by":"publisher","first-page":"105411","DOI":"10.1016\/j.jbc.2023.105411","volume":"299","author":"MR Pratt","year":"2023","unstructured":"Pratt, M. R. & Vocadlo, D. J. Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases. J. Biol. Chem. 299 (12), 105411. https:\/\/doi.org\/10.1016\/j.jbc.2023.105411 (2023).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94303-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:08:54Z","timestamp":1742368134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94303-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94303"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94303-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this study, all our GWAS data were derived from published statistical sources, thus negating the need for additional ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors unanimously agreed to submit this research achievement for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9421"}}